实现癌症易感性基因的承诺。
Realizing the promise of cancer predisposition genes.
机构信息
1] Division of Genetics and Epidemiology, Institute of Cancer Research, London SW2 5NG, UK. [2] Cancer Genetics Unit, Royal Marsden Hospital Foundation Trust, London SM2 5PT, UK.
出版信息
Nature. 2014 Jan 16;505(7483):302-8. doi: 10.1038/nature12981.
Abstract
Genes in which germline mutations confer highly or moderately increased risks of cancer are called cancer predisposition genes. More than 100 of these genes have been identified, providing important scientific insights in many areas, particularly the mechanisms of cancer causation. Moreover, clinical utilization of cancer predisposition genes has had a substantial impact on diagnosis, optimized management and prevention of cancer. The recent transformative advances in DNA sequencing hold the promise of many more cancer predisposition gene discoveries, and greater and broader clinical applications. However, there is also considerable potential for incorrect inferences and inappropriate clinical applications. Realizing the promise of cancer predisposition genes for science and medicine will thus require careful navigation.
摘要
种系基因突变赋予个体高度或中度癌症风险的基因被称为癌症易感基因。已经发现了 100 多种此类基因，这些基因在许多领域提供了重要的科学见解，尤其是在癌症发病机制方面。此外，癌症易感基因的临床应用对癌症的诊断、优化管理和预防产生了重大影响。最近 DNA 测序的突破性进展有望发现更多的癌症易感基因，并带来更广泛的临床应用。然而，也存在着错误推断和不适当的临床应用的巨大风险。因此，为了科学和医学的发展，要充分发挥癌症易感基因的潜力，就需要谨慎地进行探索。
相似文献
1
Realizing the promise of cancer predisposition genes.
Nature. 2014 Jan 16;505(7483):302-8. doi: 10.1038/nature12981.
2
Substantial batch effects in TCGA exome sequences undermine pan-cancer analysis of germline variants.
BMC Cancer. 2019 Aug 7;19(1):783. doi: 10.1186/s12885-019-5994-5.
3
Epidemiological approaches to the identification of cancer predisposition genes.
Methods Mol Biol. 2003;222:309-25. doi: 10.1385/1-59259-328-3:309.
4
Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D.
Breast. 2022 Oct;65:32-40. doi: 10.1016/j.breast.2022.06.003. Epub 2022 Jun 18.
5
Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
Clin Orthop Relat Res. 2020 Nov;478(11):2442-2450. doi: 10.1097/CORR.0000000000001239.
6
Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.
JAMA. 2017 Sep 5;318(9):825-835. doi: 10.1001/jama.2017.11137.
7
The context-specific role of germline pathogenicity in tumorigenesis.
Nat Genet. 2021 Nov;53(11):1577-1585. doi: 10.1038/s41588-021-00949-1. Epub 2021 Nov 5.
8
Loss-of-Function Variants in the Tumor-Suppressor Gene Confer Increased Cancer Risk.
Cancer Res. 2021 Apr 15;81(8):1954-1964. doi: 10.1158/0008-5472.CAN-20-3065. Epub 2021 Feb 18.
9
Investigation of clinically relevant germline variants detected by next-generation sequencing in patients with childhood cancer: a review of the literature.
J Med Genet. 2018 Dec;55(12):785-793. doi: 10.1136/jmedgenet-2018-105488. Epub 2018 Oct 4.
10
Germline copy number variations and cancer predisposition.
Future Oncol. 2012 Apr;8(4):441-50. doi: 10.2217/fon.12.34.
引用本文的文献
1
Germline Pathogenic/Likely Pathogenic Mutations and Subsequent Neoplasms Among Childhood Cancer Survivors: A Report From the Children's Oncology Group ALTE03N1 Study.
J Clin Oncol. 2025 Aug 19:JCO2500542. doi: 10.1200/JCO-25-00542.
2
Detecting likely germline variants during tumor-based molecular profiling.
J Clin Invest. 2025 Aug 1;135(15). doi: 10.1172/JCI190264.
3
Inherited Susceptibility to Cancer: Past, Present and Future.
Ann Hum Genet. 2025 Sep;89(5):354-365. doi: 10.1111/ahg.70013. Epub 2025 Jul 21.
4
Overcoming Barriers in Cancer Biology Research: Current Limitations and Solutions.
Cancers (Basel). 2025 Jun 23;17(13):2102. doi: 10.3390/cancers17132102.
5
Generating a database by calculating the pathogenic variants and allele frequencies detected in hereditary cancers using genomic data: A nation study.
Glob Med Genet. 2025 Feb 21;12(3):100052. doi: 10.1016/j.gmg.2025.100052. eCollection 2025 Sep.
6
Broadening the differential diagnosis associated with germline mutations.
Haematologica. 2025 Sep 1;110(9):1906-1908. doi: 10.3324/haematol.2025.287490. Epub 2025 May 29.
7
Whole genome sequencing improves tissue-of-origin diagnosis and treatment options for cancer of unknown primary.
Nat Commun. 2025 May 20;16(1):4422. doi: 10.1038/s41467-025-59661-x.
8
Germline pathogenic variants in DNA repair pathways: a key feature in a significant subset of translocation-associated sarcomas.
NPJ Precis Oncol. 2025 May 7;9(1):133. doi: 10.1038/s41698-025-00925-6.
9
Pathogenic germline variants in small cell lung cancer: A systematic review and meta-analysis.
HGG Adv. 2025 Apr 29;6(3):100445. doi: 10.1016/j.xhgg.2025.100445.
10
Precision proteogenomics reveals pan-cancer impact of germline variants.
Cell. 2025 May 1;188(9):2312-2335.e26. doi: 10.1016/j.cell.2025.03.026. Epub 2025 Apr 14.
本文引用的文献
1
Signatures of mutational processes in human cancer.
Nature. 2013 Aug 22;500(7463):415-21. doi: 10.1038/nature12477. Epub 2013 Aug 14.
2
A systematic review of cancer GWAS and candidate gene meta-analyses reveals limited overlap but similar effect sizes.
Eur J Hum Genet. 2014 Mar;22(3):402-8. doi: 10.1038/ejhg.2013.161. Epub 2013 Jul 24.
3
Chemoprevention in Lynch syndrome.
Fam Cancer. 2013 Dec;12(4):707-18. doi: 10.1007/s10689-013-9650-y.
4
Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome.
Science. 2013 Aug 23;341(6148):1233151. doi: 10.1126/science.1233151. Epub 2013 Jul 11.
5
Risks and benefits of screening asymptomatic women for ovarian cancer: a systematic review and meta-analysis.
Gynecol Oncol. 2013 Sep;130(3):674-81. doi: 10.1016/j.ygyno.2013.06.029. Epub 2013 Jun 30.
6
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
Genet Med. 2013 Jul;15(7):565-74. doi: 10.1038/gim.2013.73. Epub 2013 Jun 20.
7
Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update.
J Clin Endocrinol Metab. 2013 Aug;98(8):3149-64. doi: 10.1210/jc.2013-1204. Epub 2013 Jun 6.
8
CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study.
J Med Genet. 2013 Jul;50(7):486-9. doi: 10.1136/jmedgenet-2012-101472. Epub 2013 May 25.
9
Diagnosis, prognosis and treatment of patients with gastrointestinal stromal tumour (GIST) and germline mutation of KIT exon 13.
Eur J Cancer. 2013 Jul;49(11):2531-41. doi: 10.1016/j.ejca.2013.04.005. Epub 2013 May 3.
10
Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.
J Clin Oncol. 2013 May 10;31(14):1748-57. doi: 10.1200/JCO.2012.43.1882. Epub 2013 Apr 8.
Zotero 插件